Latest Research

Zivo Initial Report

Company Overview

Zivo Bioscience, Inc., formerly Health Enhancement Products, Inc., is a biotechnology company. The Company is engaged in the study, development and commercialization of naturally derived compounds and bioactive molecules created by algal and bacterial hosts. The Company focuses on research and identification of its bioactive ingredients. It focuses to sell natural bioactive ingredients derived from its algae cultures to animal, human and dietary supplement and medical food manufacturers. It is also engaged in development of biologically derived and synthetic candidates for medicinal and pharmaceutical applications in humans and animals, specifically focused on autoimmune and inflammatory response modulation. It focuses on developing, manufacturing, marketing and selling tests that allow users to optimize personal health and identify future health risks. The Company manufactures algal products and derivatives, and has various product platforms.

Market Data

+0.0108 (18.62%)
Aug 23 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.06 - 0.07
52 week 0.04 - 0.12
Open 0.06
Vol / Avg. 43,000.00/132,157.00
Mkt cap 9.65M
P/E     -
Div/yield     -
EPS -0.04
Shares 140.26M
Beta 1.97
Inst. own 0%

Key Stats

Q2 (Jun '17) 2016
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -792.86% -1496.26%
Return on average equity - -
Employees 2 -
CDP Score - -

Officers and directors

Andrew D. Dahl President, Chief Executive Officer
Age: 62
Philip M. Rice II Chief Financial Officer, Director
Age: 61
Christopher D. Maggiore Director
Age: 50
Nola E. Masterson Director
Age: 68
John B. Payne Director
Age: 68
Robert O. Rondeau Jr. Director
Age: 51